Case study: Obesity a potential risk factor for HDFN, failed RhIG
Two case studies showed that obesity may cause RhIG treatment to be ineffective, leading to the development of HDFN.
Two case studies showed that obesity may cause RhIG treatment to be ineffective, leading to the development of HDFN.
Researchers of a large-scale study of blood donors in Indonesia aim to optimize transfusion guidelines at the national level.
A recent study showed that a second alloimmunization screening test could help diagnose more women and lead to earlier treatment in HDFN.
A recently published survey sought to determine how treatment methods for RhD-negative patients were affected by the COVID-19 pandemic.
A recent case report described a pregnant woman who had a weak D-phenotype was successfully treated without anti-D therapy.
A recently published study showed IVIG treatment in pregnancies at risk of severe HDFN resulted in more positive outcomes for the fetus.
A recent study showed that performing intrauterine transfusions on or after 34 weeks gestational age could result in later deliveries.
A recent case study showed antibody screening in early pregnancy could play a key role in lessening the risks linked to development of HDFN.
Results of five surveys showed respondents valued improving their chances of survival in trauma by accepting an urgent transfusion despite the risk of HDFN.
A recent survey showed practices vary across the U.S. in testing, reporting and monitoring practices of patients at risk of HDFN.